loading
前日終値:
$1.565
開ける:
$1.69
24時間の取引高:
32.67M
Relative Volume:
51.01
時価総額:
$39.90M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+28.84%
1か月 パフォーマンス:
+46.16%
6か月 パフォーマンス:
-4.43%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$1.57
$1.76
1週間の範囲:
Value
$1.30
$1.76
52週間の値動き範囲:
Value
$1.04
$3.50

Rein Therapeutics Inc Stock (RNTX) Company Profile

Name
名前
Rein Therapeutics Inc
Name
セクター
Healthcare (1137)
Name
電話
(737) 802-1989
Name
住所
12407 N. MOPAC EXPY., AUSTIN
Name
職員
11
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
RNTX's Discussions on Twitter

RNTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RNTX
Rein Therapeutics Inc
1.712 37.60M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.74 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
640.57 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
444.54 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
824.40 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
183.00 40.44B 447.02M -1.18B -868.57M -6.1812

Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-22 開始されました H.C. Wainwright Buy
2025-01-28 開始されました Rodman & Renshaw Buy
2017-07-24 開始されました BofA/Merrill Buy
2017-07-24 開始されました Jefferies Buy
2017-07-24 開始されました William Blair Outperform

Rein Therapeutics Inc (RNTX) 最新ニュース

pulisher
07:55 AM

Rein Therapeutics Receives FDA Clearance to Resume Phase 2 Trial - TradingView

07:55 AM
pulisher
07:36 AM

Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - The Manila Times

07:36 AM
pulisher
05:49 AM

How Rein Therapeutics Inc. stock reacts to bond yieldsJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com

05:49 AM
pulisher
05:14 AM

Ranking Rein Therapeutics Inc. among high performing stocks via toolsQuarterly Investment Review & Weekly Hot Stock Watchlists - newser.com

05:14 AM
pulisher
03:39 AM

Technical signs of recovery in Rein Therapeutics Inc.July 2025 Catalysts & Community Consensus Stock Picks - newser.com

03:39 AM
pulisher
02:57 AM

Multi asset correlation models including Rein Therapeutics Inc.Weekly Trend Summary & Daily Growth Stock Tips - newser.com

02:57 AM
pulisher
12:53 PM

Why Rein Therapeutics Inc. stock attracts high net worth investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com

12:53 PM
pulisher
12:08 PM

News impact scoring models applied to Rein Therapeutics Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com

12:08 PM
pulisher
Nov 02, 2025

Price momentum metrics for Rein Therapeutics Inc. explainedEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Rein Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Rein Therapeutics Inc. potential2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why retail investors pile into Rein Therapeutics Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Rein Therapeutics Inc. stock retracement – recovery analysis2025 Geopolitical Influence & AI Driven Price Predictions - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Rein Therapeutics Inc. Stock (RNTX) Opinions on Institutional Investments and Funding Deals - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 28, 2025

Is Rein Therapeutics Inc. stock a defensive play in 20252025 Market WrapUp & AI Based Trade Execution Alerts - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

How rising interest rates impact Rein Therapeutics Inc. stock2025 Growth vs Value & AI Driven Stock Reports - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

VIX Spike: How rising interest rates impact Rein Therapeutics Inc. stockBond Market & Real-Time Volume Analysis Alerts - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

Applying sector rotation models to Rein Therapeutics Inc.2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com

Oct 27, 2025

Rein Therapeutics Inc (RNTX) 財務データ

Rein Therapeutics Inc (RNTX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rein Therapeutics Inc (RNTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Voss Capital, LP
10% Owner
Oct 27 '25
Buy
1.37
97,482
133,544
822,258
Voss Capital, LP
10% Owner
Oct 24 '25
Buy
1.39
30,176
41,957
729,616
WINDSOR JAMES BRIAN
President and CEO
Dec 05 '24
Buy
2.24
400
898
239
$37.52
price up icon 0.03%
$93.16
price down icon 0.32%
$28.84
price up icon 0.79%
$104.30
price up icon 0.20%
biotechnology ONC
$313.33
price up icon 0.97%
$184.11
price down icon 2.65%
大文字化:     |  ボリューム (24 時間):